Yang X, Liu H, Wu X
Clin Exp Med. 2025; 25(1):79.
PMID: 40063280
PMC: 11893705.
DOI: 10.1007/s10238-025-01577-3.
Porada M, Buldak L
Metabolites. 2025; 15(2).
PMID: 39997697
PMC: 11857179.
DOI: 10.3390/metabo15020072.
Ahmadi A, Klein R, Gao D, Mielniczuk L, Zelt J, Boczar K
Mol Imaging Biol. 2025; .
PMID: 39939405
DOI: 10.1007/s11307-025-01987-5.
Ito S, Yoshitani K, Fukushima S, Matsuda H
J Cardiovasc Echogr. 2025; 34(4):170-178.
PMID: 39895890
PMC: 11784735.
DOI: 10.4103/jcecho.jcecho_38_24.
Sercelik A, Askin L
J Res Med Sci. 2025; 29:75.
PMID: 39871874
PMC: 11771819.
DOI: 10.4103/jrms.jrms_350_24.
Evolving perspectives on aortic stenosis: the increasing importance of evaluating the right ventricle before aortic valve intervention.
Androshchuk V, Chehab O, Wilcox J, McDonaugh B, Montarello N, Rajani R
Front Cardiovasc Med. 2025; 11():1506993.
PMID: 39844905
PMC: 11750849.
DOI: 10.3389/fcvm.2024.1506993.
Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of outcome in acute heart failure.
Antit S, Mrabet A, Fathi M, Fekih R, Boussabeh E, Zakhama L
Tunis Med. 2025; 103(1):104-111.
PMID: 39812202
PMC: 11906249.
DOI: 10.62438/tunismed.v103i1.5365.
The selective serotonin reuptake inhibitor paroxetine improves right ventricular systolic function in experimental pulmonary hypertension.
Waddingham M, Tsuchimochi H, Sonobe T, Sequeira V, Nayeem M, Shirai M
J Mol Cell Cardiol Plus. 2025; 8():100072.
PMID: 39802918
PMC: 11708357.
DOI: 10.1016/j.jmccpl.2024.100072.
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications.
Osgueritchian R, Mombeini H, Jani V, Hsu S, Hummers L, Wigley F
Curr Cardiol Rep. 2025; 27(1):3.
PMID: 39754676
PMC: 11864186.
DOI: 10.1007/s11886-024-02164-w.
In Vivo Anti-Inflammatory Activity of D-Limonene in a Rat Model of Monocrotaline-Induced Pulmonary Hypertension: Implications to the Heart Function.
Teixeira-Fonseca J, Orts D, Silva P, Conceicao M, Hermes H, Prudencio C
Arq Bras Cardiol. 2024; 121(12):e20240195.
PMID: 39699454
PMC: 11634294.
DOI: 10.36660/abc.20240195.
Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease from the PVDOMICS Study.
Mukherjee M, Mathai S, Jellis C, Freed B, Yanek L, Agoglia H
Circ Cardiovasc Imaging. 2024; 17(10).
PMID: 39691460
PMC: 11649025.
DOI: 10.1161/circimaging.124.017074.
Right ventricular stroke work index in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A retrospective observational study.
Csosza G, Valko L, Dinya E, Losonczy G, Muller V, Lazar Z
Pulm Circ. 2024; 14(4):e12433.
PMID: 39678730
PMC: 11645440.
DOI: 10.1002/pul2.12433.
Population Pharmacokinetic/Pharmacodynamic and Exposure-Response Modeling Analyses of Sotatercept in Healthy Participants and Patients with Pulmonary Arterial Hypertension.
Ait-Oudhia S, Jaworowicz D, Hu Z, Gaurav M, Barcomb H, Hu S
Clin Pharmacol Ther. 2024; 117(3):798-807.
PMID: 39668469
PMC: 11835429.
DOI: 10.1002/cpt.3524.
Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension.
Vitulo P, Piccari L, Wort S, Shlobin O, Kovacs G, Vizza C
Pulm Circ. 2024; 14(4):e70005.
PMID: 39659477
PMC: 11629413.
DOI: 10.1002/pul2.70005.
A combination of clinical, electrocardiographic, and echocardiographic parameters predicts pulmonary hypertension occurrence in patients with end-stage renal disease.
Ding H, Ding H, Zhang F, Zhong J, Pan J, Chen Y
Front Cardiovasc Med. 2024; 11:1337243.
PMID: 39624220
PMC: 11609933.
DOI: 10.3389/fcvm.2024.1337243.
Deep phenotyping the right ventricle to establish translational MRI biomarkers for characterization of adaptive and maladaptive states in pulmonary hypertension.
Baxan N, Zhao L, Ashek A, Niglas M, Wang D, Khassafi F
Sci Rep. 2024; 14(1):29774.
PMID: 39616208
PMC: 11608234.
DOI: 10.1038/s41598-024-79029-3.
Cardiac Failure and Cardiogenic Shock: Insights Into Pathophysiology, Classification, and Hemodynamic Assessment.
Siopi S, Antonitsis P, Karapanagiotidis G, Tagarakis G, Voucharas C, Anastasiadis K
Cureus. 2024; 16(10):e72106.
PMID: 39575019
PMC: 11581444.
DOI: 10.7759/cureus.72106.
When pulmonary arterial hypertension and pregnancy meet: a multidisciplinary clinical experts review.
Dominoni M, Melito C, Schirinzi S, Ghio S, Scelsi L, Greco A
Arch Gynecol Obstet. 2024; 310(6):2839-2852.
PMID: 39570387
DOI: 10.1007/s00404-024-07827-1.
Asymmetric right ventricular myocardial work correlates with gold standard measurements of cardiac function in pulmonary hypertension.
Diab S, Ebata R, Mroczek D, Hui W, Remme E, Moller T
Pulm Circ. 2024; 14(4):e70014.
PMID: 39554312
PMC: 11569406.
DOI: 10.1002/pul2.70014.
Effects of dopamine β-hydroxylase inhibition in pressure overload-induced right ventricular failure.
Andersen S, Axelsen J, Nielsen-Kudsk A, Schwab J, Jensen C, Ringgaard S
Pulm Circ. 2024; 14(4):e70008.
PMID: 39539945
PMC: 11558268.
DOI: 10.1002/pul2.70008.